This paper is also available in Vietnamese.</a></p>" /> This paper is also available in Vietnamese.</a></p>" />
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreGet the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.
Read The Latest IssueImproving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
Search JobsCardiovascular disease (CVD) is the leading cause of death and disability globally, with atherosclerotic cardiovascular disease (ASCVD) constituting to the brunt of the disease. ASCVD has also resulted in significant productivity loss in the Asia Pacific region, including Vietnam. Immediate attention is needed from the government authorities, in which failure to do so will result in further economic and health deterioration. This white paper will explore the unmet needs of CVD, as well as suggest strategies to address the growing disease burden and avoid a future public health crisis.